Most Americans won’t get Pfizer vaccine until June, because Trump passed on opportunity to buy more
As The New York Times reports, Trump had a chance to secure millions more doses of Pfizer’s mRNA-based vaccine. Obtaining those doses for the nation didn’t require a long-shot bet made way back at the beginning of the pandemic. That chance came in early November, when good results from Phase 2 trials had already been analyzed and Phase 3 results were just days away.
Read more